Rho, a clinical research organization based in Chapel Hill, had won a seven-year contract with a division of the National Institute of Allergy and Infectious Diseases worth some $115 million. It’s the largest federal contract in the history of the 31-year-old company.
Rho will provide statistical and clinical coordination services for the Division of Allergy, Immunology and Transplantation.
The contract is valued at $16.5 per year, but the first year of the agreement will be worth more with another $6.8 million in who Rho calls “supplemental funds.”
“Rho is excited to be selected as DAIT’s Statistical and Clinical Coordinating Center to support the important work they are doing to help combat serious health concerns, such as asthma and allergies, autoimmune diseases, and transplantation,” said Russ Helms, Chief Executive Officer for Rho. “Rho’s expertise and resources will help assure top-notch operational support, statistical analysis, clinical data management and bioinformatics services.”
Five Rho employees will serve as principal investigators on the project:
- Ronald W. Helms, Ph.D., Chairman and overall PI
- Karen Kesler, Ph.D., Senior Statistical Scientist and Leadership Group PI
- Samuel Arbes, Jr., D.D.S., M.P.H., Ph.D., Senior Research Scientist and Group Leader for the Asthma and Allergic Diseases Group
- David Ikle, Ph.D., Senior Statistical Scientist and Group Leader for the Transplantation Group; and Lynette Keyes-Elstein, DrPH, Senior Statistical Scientist and Group Leader for the Autoimmune Diseases Group.
- Michelle Walter, M.S., Senior Project Director will provide daily management.
